EGFR and lung cancer: Ectopic expression of receptor tyrosine kinases (RTKs) has been proved to play a vital role in lung cancer, and recently, tyrosine kinase inhibitors targeting EGFR are hot spots of targeting therapy in variety of cancer types (22).